Germany will take a stake in unlisted biotech firm CureVac, which is working on a COVID-19 vaccine, Economy Minister Peter Altmaier said on Monday, confirming an earlier Reuters report.
The move followed reported attempts by the U.S. government to acquire CureVac or its assets in March, which stirred a backlash in Berlin, with Altmaier and the interior minister voicing support for keeping CureVac German.
Altmaier said that the government wanted to strengthen the life sciences and biotech sectors in Germany and that Berlin would not have any influence over CureVac’s business strategy.“The German Federal government has decided to invest in this promising company because it expects that this will accelerate development programs and provide the means for CureVac to harness the full potential of its technology,” he told a new conference.
Additional reporting by Holger Hansen in Berlin and Patricia Uhlig in Frankfurt; Editing by Sabine Wollrab, Michelle Martin and Carmel Crimmins
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
AstraZeneca agrees to supply Europe with 400 million doses of COVID-19 vaccineAstraZeneca Plc said on Saturday it signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help combat the pandemic.
続きを読む »
France expects AstraZeneca COVID-19 vaccine to be shared pro rataA deal between AstraZeneca and France over potential COVID-19 vaccines involves doses being split between countries on a pro-rata basis based on population, a source at the French President's office said on Monday.
続きを読む »
AstraZeneca agrees to make COVID-19 vaccine for EuropePharma giant AstraZeneca has struck a deal to supply up to 400 million doses of an experimental COVID-19 vaccine to European Union countries.
続きを読む »
The Hideous Truths Of Testing Vaccines On HumansSixty years ago, a monstrous hepatitis experiment was performed on mentally disabled children at Willowbrook State School that raises serious ethical questions about vaccine challenge trials for Covid-19.
続きを読む »
The Hideous Truths Of Testing Vaccines On HumansSixty years ago, a monstrous hepatitis experiment was performed on mentally disabled children at Willowbrook State School that raises serious ethical questions about vaccine challenge trials for Covid-19.
続きを読む »
The Hideous Truths Of Testing Vaccines On HumansWhile the vaccine trials would be done with healthy adult volunteers, the Covid-19 vaccine challenge trial and the Willowbrook hepatitis experiments beg the same question: Is it really necessary—or right—to risk the health of a few for the benefit of many?
続きを読む »